Skip to content

Maxillary sinus augmentation using different osseodensification protocols: a retrospective study with 3-year follow-up

Sinus floor elevation using osseodensification protocols I, II and III: a retrospective study with 36 months follow-up

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17397796
Enrollment
190
Registered
2025-10-06
Start date
2019-02-06
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental implant stability Oral Health

Interventions

The participants provided their informed consent after being thoroughly enlightened about the goal and methods of the study both orally and in writing. A meticulous clinical examination, an assessmen

Sponsors

Cooperativa de Ensino Superior Politécnico e Universitário
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old 2. Healed edentulous sites in the posterior maxilla with residual bone height between 2 and 8 mm to facilitate the placement of implants requiring sinus grafting procedures after prior analysis with Cone Beam computer Tomography (CBCT, New Tom® Go 3D, CEFLA S.C., Imola (BO) Italy)

Exclusion criteria

Exclusion criteria: 1. Irradiated patients 2. Impaired immune systems 3. Smoking, drug abuse or alcoholism 4. Diabetes 5. Heart disease 6. Bleeding disorders 7. Sinus pathology 8. Previous bone augmentation 9. Past or current usage of steroids or bisphosphonates

Design outcomes

Primary

MeasureTime frame
Insertion torque (IT) measured using a manual torque wrench (Straumann®, Basel, Switzerland) and resonance frequency analysis (RFA) on the day of implant placement

Secondary

MeasureTime frame
The implant stability quotient (ISQ) value was recorded as the average of buccal, lingual, mesial, and distal measurements using Osstell® IDX (Osstell, W&H, Gothenburg, Sweden) immediately after implant placement (T1); 1 year after implant placement (T2); 2 years of follow-up (T3); 3 years of follow-up (T4)

Countries

Portugal

Contacts

Public ContactRosana Costa
rosana.costa@iucs.cespu.pt+351 (0)914240555

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026